AU4742101A - Antagonists of gonadotropin releasing hormone - Google Patents
Antagonists of gonadotropin releasing hormoneInfo
- Publication number
- AU4742101A AU4742101A AU47421/01A AU4742101A AU4742101A AU 4742101 A AU4742101 A AU 4742101A AU 47421/01 A AU47421/01 A AU 47421/01A AU 4742101 A AU4742101 A AU 4742101A AU 4742101 A AU4742101 A AU 4742101A
- Authority
- AU
- Australia
- Prior art keywords
- antagonists
- releasing hormone
- gonadotropin releasing
- gonadotropin
- hormone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19041600P | 2000-03-17 | 2000-03-17 | |
| US60190416 | 2000-03-17 | ||
| PCT/US2001/008145 WO2001070228A1 (en) | 2000-03-17 | 2001-03-13 | Antagonists of gonadotropin releasing hormone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4742101A true AU4742101A (en) | 2001-10-03 |
Family
ID=22701254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU47421/01A Withdrawn AU4742101A (en) | 2000-03-17 | 2001-03-13 | Antagonists of gonadotropin releasing hormone |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU4742101A (en) |
| WO (1) | WO2001070228A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6822097B1 (en) | 2002-02-07 | 2004-11-23 | Amgen, Inc. | Compounds and methods of uses |
| JP2006503008A (en) * | 2002-08-13 | 2006-01-26 | ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー | 4-Hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
| GB0223730D0 (en) * | 2002-10-11 | 2002-11-20 | Novartis Ag | Organic compounds |
| EP1692111A2 (en) | 2003-12-12 | 2006-08-23 | Wyeth, A Corporation of the State of Delaware | Quinolines useful in treating cardiovascular disease |
| GB0412769D0 (en) | 2004-06-08 | 2004-07-07 | Novartis Ag | Organic compounds |
| JP2008503482A (en) | 2004-06-18 | 2008-02-07 | ワイス | Process for producing 6-alkyl-5-arylsulfonyl-dihydrophenanthridine |
| AU2007210061A1 (en) * | 2006-01-30 | 2007-08-09 | Merck Sharp & Dohme Corp. | Inhibitors of fatty acid synthase (FAS) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6147088A (en) * | 1996-05-20 | 2000-11-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| WO1997044339A1 (en) * | 1996-05-20 | 1997-11-27 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
-
2001
- 2001-03-13 AU AU47421/01A patent/AU4742101A/en not_active Withdrawn
- 2001-03-13 WO PCT/US2001/008145 patent/WO2001070228A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001070228A1 (en) | 2001-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3008997A (en) | Antagonists of gonadotropin releasing hormone | |
| AU4834900A (en) | Antagonists of gonadotropin releasing hormone | |
| AU3071397A (en) | Antagonists of gonadotropin releasing hormone | |
| AU2001255798A1 (en) | Glucagon antagonists | |
| AU2002231098A1 (en) | Nonpeptide agonists and antagonists of vasopressin receptors | |
| AU2001269876A1 (en) | Heteroarylalkanoic acids as integrin receptor antagonists | |
| AU3141197A (en) | Antagonists of gonadotropin releasing hormone | |
| EP0901471A4 (en) | Antagonists of gonadotropin releasing hormone | |
| AU2001225663A1 (en) | A composition comprising a combination of receptor agonists and antagonists | |
| AU4742101A (en) | Antagonists of gonadotropin releasing hormone | |
| AU4738101A (en) | Antagonists of gonadotropin releasing hormone | |
| AU2001271018A1 (en) | Gpr14 antagonist | |
| AU2001275362A1 (en) | Nuclear hormone receptors | |
| AU2002231989A1 (en) | Antagonists of gonadotropin releasing hormone | |
| AU2002351468A1 (en) | Rescue of gonadotropin releasing hormone receptor mutants | |
| GB9811286D0 (en) | Antagonists of gonadotropin releasing hormone | |
| GB9805717D0 (en) | Antagonists of gonadotropin releasing hormone | |
| GB9800450D0 (en) | Antagonists of gonadotropin releasing hormone | |
| GB9823087D0 (en) | Antagonists of gonadotropin releasing hormone | |
| GB9815847D0 (en) | Antagonists of gonadotropin releasing hormone | |
| GB9809789D0 (en) | Antagonists of gonadotropin releasing hormone | |
| GB9815854D0 (en) | Antagonists of gonadotropin releasing hormone | |
| GB9800451D0 (en) | Antagonists of gonadotropin releasing hormone | |
| GB9811294D0 (en) | Antagonists of gonadotropin releasing hormone | |
| GB9805718D0 (en) | Antagonists of gonadotropin releasing hormone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK13 | Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant |